# STereotactic Body Radiotherapy (SBRT) for Oligoprogressive Breast Cancer

> **NCT06489821** · NA · NOT_YET_RECRUITING · sponsor: **Juravinski Cancer Center** · enrollment: 36 (estimated)

## Conditions studied

- Metastatic Breast Cancer
- Oligoprogression

## Interventions

- **RADIATION:** Stereotactic body radiotherapy

## Key facts

- **NCT ID:** NCT06489821
- **Lead sponsor:** Juravinski Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-09-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2024-07-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06489821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06489821, "STereotactic Body Radiotherapy (SBRT) for Oligoprogressive Breast Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06489821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*